A phase II, randomized, double-blind, placebo controlled, multicenter, study to evaluate the efficacy and safety of intravenous Prasinezumab in participants with early Parkinson Disease
Topic / Pathology
- Parkinson's Disease
Objectives
To have more informations, click on the link below:
https://clinicaltrials.gov/ct2/show/NCT04777331?term=padova&cond=Parkin…
Sponsor
Roche
Status
Recruitment completed
Participating centers
- Centre de Bordeaux
- Centre de Clermont-Ferrand
- Centre de Creteil - Hôpital Henri Mondor
- Centre de Grenoble
- Centre de Limoges
- Centre de Lyon
- Centre de Marseille
- Centre de Montpellier
- Centre de Nantes
- Centre de Nice
- Centre de Paris - Pitié Salpetriere
- Centre de Poitiers
- Centre de Rouen
- Centre de Strasbourg
- Centre de Toulouse
